However, the present treatments for CM are not satisfactory [6], and the pathogenesis of CM is still not fully understood
While hormone therapy is not a weight-loss drug (and should not be used as one), it can improve glucose control in [people with diabetes], and is associated with fewer cases of diabetes, says Faubion
L-carnitine Some formulations include L-carnitine for its potential metabolic benefits
PlexusDx Compounded Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan), while the oral version is $349/mo month-to-month, or from $279/mo on the 6-month plan, both supplied from licensed 503A compounding pharmacies that meet rigorous quality and sterility standards
Substantial and sustained weight loss, even in individuals without diabetes
Successful treatment of underlying hypogonadism (if present) in conjunction with PT-141 might yield better outcomes, though thats more about identifying other factors rather than measuring PT-141s effect